Editas Medicine (EDIT) Times Interest Earned (2015 - 2025)
Editas Medicine's (EDIT) quarterly Times Interest Earned came in at -$3.25 in Q3 2025, up 84.2% on a QoQ basis from -$20.58 in Q2 2025.
Editas Medicine (EDIT) Times Interest Earned (2015 - 2025) Analysis & Trends
Editas Medicine (EDIT) has 11 years of Times Interest Earned data on file, last reported at -$3.25 in Q3 2025.
- On a quarterly basis, Times Interest Earned changed N/A year-over-year to -$3.25 in Q3 2025; TTM through Sep 2025 was -$26.33, a 37.66% increase from a year earlier, with the FY2024 full-year figure at -$13.61, down 2544.64% from the prior year.
- Times Interest Earned for Q3 2025 stood at -$3.25, up from -$20.58 in the prior quarter.
- Over the last five years, Times Interest Earned for EDIT reached as high as $22.11 in Q4 2022 and fell as low as -$20.58 in Q2 2025.
- Historically, Times Interest Earned has averaged -$3.01 across 5 years, with a median of -$0.73 in 2021.
- Across the five-year window, Times Interest Earned surged 310.19% in 2022 and slumped 7981.55% in 2024, its largest moves.
- Year by year, Times Interest Earned stood at $5.39 in 2021, then jumped by 310.19% to $22.11 in 2022, then slumped by 169.28% to -$15.32 in 2023, then soared by 76.18% to -$3.65 in 2024, then advanced by 10.94% to -$3.25 in 2025.
- Per Business Quant data, the three most recent Times Interest Earned figures were -$3.25 in Q3 2025, -$20.58 in Q2 2025, and -$14.09 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Editas Medicine | 245.95 Mn | 99.30 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -3.25 |
| Jun 30, 2025 | -20.58 |
| Mar 31, 2025 | -14.09 |
| Dec 31, 2024 | -3.65 |
| Mar 31, 2024 | -17.41 |
| Dec 31, 2023 | -15.32 |
| Sep 30, 2023 | -0.57 |
| Jun 30, 2023 | -0.09 |
| Mar 31, 2023 | -0.22 |
| Dec 31, 2022 | 22.11 |
| Sep 30, 2022 | -0.04 |
| Jun 30, 2022 | -0.05 |
| Mar 31, 2022 | -0.01 |
| Dec 31, 2021 | 5.39 |
| Sep 30, 2021 | -1.38 |
| Jun 30, 2021 | -0.73 |
| Mar 31, 2021 | -1.31 |
| Dec 31, 2020 | -32.89 |
| Sep 30, 2020 | 0.72 |
| Jun 30, 2020 | -1.77 |